Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. USNA
  6. >
  7. Earnings
stocks logo

USNA Earnings

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings

Earning Analysis

Welcome to our in-depth analysis of USANA Health Sciences Inc(USNA) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of USANA Health Sciences Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2025Q32025-10-22After Hours-0.15-0.15-213.88M213.67M-0.10-1.34-2.77
FY2025Q22025-07-22After Hours0.540.74+37.04225.20M235.85M+4.73+12.37-0.29
FY2024Q42025-02-25After Hours0.490.64+30.61208.82M213.61M+2.29+3.91-7.38
FY2024Q32024-10-22After Hours0.490.56+14.29205.77M200.22M-2.70+6.09+8.18
FY2024Q22024-07-23-0.650.54-16.92220.97M212.87M-3.67-0.52-6.06
FY2024Q12024-04-30-0.690.86+24.64226.84M227.80M+0.42-3.40+3.79
FY2023Q42024-02-06-0.520.87+67.31212.42M221.08M+4.08+2.95+12.77
FY2023Q32023-10-24-0.640.59-7.81220.42M213.37M-3.20+1.59-15.32
-2023-07-25-0.700.89+27.14----0.63+1.76
-2023-04-25-0.770.95+23.38----3.28+3.43
Intellectia AI SwingMax
Intellectia AI SwingMax

USNA Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, USANA Health Sciences Inc reported performance for FY2025Q3, announced on 2025-10-22. The company achieved an EPS of -0.15, compared to analyst estimates of -0.15 by 0.00% . Revenue for the quarter reached 213.67M compared to expectations of 213.88M by -0.10% .
The stock price reacted with a -1.34% one-day change and a -2.77% five-day change following the earnings release. These movements reflect market reaction in USANA Health Sciences Inc growth trajectory and strategic initiatives.

USNA Earnings Forecast

Looking ahead, USANA Health Sciences Inc(USNA) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 221.35M and an EPS of 0.40.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.09%, while EPS estimates have been Revise Upward by 1.76%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 0.47% . These revisions correlate with a -38.37% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in USANA Health Sciences Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between USNA's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.09%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.76%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Upward
up Image
+0.47%
In Past 3 Month
Stock Price
Go Down
down Image
-38.37%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:920.41M
--
EPS Estimate-Annual FY 2025:1.73
—
Stock Price19.61
Financial AI Agent
Financial AI Agent

USNA Revenue and EPS Performance: A Historical Perspective

USANA Health Sciences Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-10-22,After Hours):
EPS: -0.15 (Actual) vs.-0.15 (Estimate) (0.00%)
Revenue: 213.67M (Actual) vs. 213.88M (Estimate) (-0.10%)
Price Reaction: -1.34%(1-Day), -2.77%(5-Day)
FY2025Q2 (2025-07-22,After Hours):
EPS: 0.74 (Actual) vs.0.54 (Estimate) (37.04%)
Revenue: 235.85M (Actual) vs. 225.20M (Estimate) (4.73%)
Price Reaction: 12.37%(1-Day), -0.29%(5-Day)
FY2024Q4 (2025-02-25,After Hours):
EPS: 0.64 (Actual) vs.0.49 (Estimate) (30.61%)
Revenue: 213.61M (Actual) vs. 208.82M (Estimate) (2.29%)
Price Reaction: 3.91%(1-Day), -7.38%(5-Day)
Earnings Reaction
The chart below shows how USNA performed 10 days before and after its earnings report, based on data from the past quarters. Typically, USNA sees a +3.34% change in stock price 10 days leading up to the earnings, and a +0.14% change 10 days following the report. On the earnings day itself, the stock moves by -0.36%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -1.34% on the day following the earnings release and then changed by -2.39% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
AI Stock Picker
AI Stock Picker

Transcript Summary

USANA Health Sciences Inc (USNA) Q3 2025 Earnings Call Summary
Neutral
2025-10-23
The earnings call highlights mixed signals: positive sales growth for Hiya and Rise Bar, promising trends from the new compensation plan, and strategic incentives planned for Q4. However, challenges include short-term margin pressures, potential operational disruptions from cost reductions, and uncertainties in supply chain transitions. The Q&A reveals management's confidence in growth, but lacks specifics on cost savings and Hiya's margin impact. Without clear guidance, the market may react cautiously, leading to a neutral stock price movement prediction.
USANA Health Sciences Inc (USNA) Q2 2025 Earnings Call Summary
Positive
2025-07-23
The earnings call reveals strong financial performance, with debt repayment, robust growth in Hiya and Rise Bar, and a new partnership with Disney. The Q&A section addresses concerns about customer decline and tariffs, with management expressing optimism for future growth. The new incentive program and potential share buybacks are positive indicators. Despite some uncertainties, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8% over the next two weeks.
USANA Health Sciences, Inc. (USNA) Q3 2024 Earnings Call Summary
Negative
2024-10-23
The earnings call reveals a challenging operating environment, especially in China, with a decline in net sales despite increased customer counts. The company faces risks from uncertain product launch success and economic factors. The lack of a share buyback program and unclear management responses further contribute to a negative sentiment. Although there are strategic initiatives and product launches, the immediate impact on financials is limited. Increased promotional activity and guidance for a challenging environment suggest potential margin pressures, leading to a negative outlook for the stock price in the short term.
USANA Health Sciences, Inc. (USNA) Q2 2024 Earnings Call Summary
Negative
2024-07-25
The earnings call reveals several concerning factors: a decline in revenue, gross margin, and net income, alongside macroeconomic pressures and restructuring challenges. Despite optimistic guidance and strategic initiatives, the lack of clear timelines for restructuring benefits and market expansion risks in India add uncertainty. The share buyback program is a positive, but not enough to offset overall negative sentiment. Analysts' concerns during the Q&A further highlight uncertainties. Without market cap data, assuming moderate sensitivity, the stock price is likely to experience a negative movement in the range of -2% to -8%.

People Also Watch

FAQ

arrow icon

What were the key highlights of USNA’s latest earnings report for FY2025Q3?

USNA reported its FY2025Q3 earnings on 2025-10-22, showcasing a revenue of 213.67M against an estimate of 213.88M, resulting in a -0.1% surprise. The EPS was -0.15, surpassing the expected -0.15 by 0% . The stock experienced a -1.34% price change on the earnings day and a -2.77% change over the next five days, reflecting market reactions to the results.
arrow icon

How did USNA’s stock price react after the FY2025Q3 earnings release?

Following USNA’s FY2025Q3 earnings announcement on 2025-10-22, the stock price moved by -1.34% on the day of the release. Over the subsequent five days, it saw a -2.77% change. Historically, USNA’s stock price tends to shift by an average of +3.34% in the 10 days leading up to earnings and +0.14% in the 10 days following, providing insight into potential market.
arrow icon

What are the revenue and EPS estimates for USNA for 2025/Q4?

For 2025/Q4, analysts estimate USNA’s annual revenue to reach 221.35M, while the EPS is projected at 0.40. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.09% and EPS estimates Revise Upward by 0.47% over the past three months, indicating analyst expectation in the company’s performance.
arrow icon

How does USNA’s stock price correlate with earnings forecast revisions?

The correlation between USNA’s stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 0.09%, while EPS estimates moved Revise Upward by 0.47% . This trend suggests that price dips could present buying opportunities for investors.
arrow icon

What should investors expect from USNA’s next earnings report?

Based on historical trends, USNA’s stock price typically moves by +3.34% in the 10 days before its earnings and +0.14% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.40 and revenue of 221.35M.
arrow icon

What is the sentiment in USANA Health Sciences Inc (USNA) Q3 2025 Earnings Call Summary?

The earnings call highlights mixed signals: positive sales growth for Hiya and Rise Bar, promising trends from the new compensation plan, and strategic incentives planned for Q4. However, challenges include short-term margin pressures, potential operational disruptions from cost reductions, and uncertainties in supply chain transitions. The Q&A reveals management's confidence in growth, but lacks specifics on cost savings and Hiya's margin impact. Without clear guidance, the market may react cautiously, leading to a neutral stock price movement prediction.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free